Urology · Acibadem Kozyatagi Hospital, İstanbul Prof. Hakan Özveri, MD
✓ Medically verified profileProf. Hakan Özveri, MD
Prof. Hakan Özveri, MD is a urologist at Acibadem Kozyatagi Hospital in İstanbul, Turkey. His practice focuses on prostate diseases, including benign prostatic hyperplasia and prostate cancer, as well as kidney diseases and stones, bladder conditions, urinary incontinence, undescended testis, testicular cancer, urogynecology and cystoscopy. He consults in Turkish and English, and video consultation is available.
Accepting international patientsAbout Prof. Hakan Özveri, MD
Prof. Hakan Özveri, MD is a urologist at Acibadem Kozyatagi Hospital in İstanbul, where he practices within the Urology unit. His subspecialty areas are the diagnosis and treatment of prostate diseases and urogynecology. He has more than 35 years in medicine and has been with Acıbadem Healthcare Services since 2004.
Dr. Özveri graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 1991 and completed his urology specialty training at Marmara University Faculty of Medicine Department of Urology between 1992 and 1997. In 1997 he undertook a fellowship at Boston Medical Center Department of Andrology in the United States, as well as a fellowship in endourology and uro-oncology at Sackler Faculty of Medicine Assaf Harofeh Medical Center in Israel. From 1997 to 2004 he worked at Üro-Tıp Urology Diagnostic Center. He is a member of the Endoüroloji Association, the Türk Androloji Association, the European Urology Association, the Turkish Urology Association and the Turkish Uro-Oncology Association. He has co-authored peer-reviewed publications on topics including anesthesia for transrectal prostate biopsy, early diagnosis and staging of prostate cancer, the role of bisphosphonates in prostate cancer treatment and neoadjuvant chemotherapy in invasive bladder cancer, with articles appearing in journals such as European Urology, Prostate Cancer and Prostatic Diseases and the Journal of BUON.
Clinical focus
A central part of Dr. Özveri’s practice is the diagnosis and treatment of prostate diseases. This includes the evaluation and management of benign prostatic hyperplasia and prostate cancer. He also treats testicular cancer and undescended testis.
Beyond prostate and testicular conditions, his areas of expertise cover kidney diseases and kidney stones, bladder health and diseases, and urinary incontinence. His work in urogynecology addresses urological conditions affecting women, including incontinence. Diagnostic procedures in his practice include cystoscopy, which allows direct examination of the bladder and urethra. The choice of investigation and treatment depends on the individual patient’s findings and is discussed with the patient after evaluation.
How Dr. Özveri works with international patients
Dr. Özveri consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. The international patient team coordinates the collection of prior reports and imaging, arranges appointments and organises the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the available options. Video consultation is available for international patients who wish to discuss their situation before traveling, which may help clarify whether an in-person visit is appropriate and what further investigations might be needed.
What Dr. Özveri treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceDiagnosis and treatment of prostate diseasesÜrojinekolojiUrogynecology
Conditions treated
Education, career and memberships
Education & training
Education
- 1997Marmara University Faculty of Medicine Urology
- 1991İstanbul University Cerrahpaşa Faculty of Medicine
Career
Professional Experience
- 2004Acıbadem Healthcare Services
- 1997–2004Üro-Tıp Urology Diagnostic Center
- 1997–2004Üro-Tıp Urology Diagnostic Center
- 1997Boston Medical Center Department of Andrology,A.B.D./ Fellowship
- 1997Sackler Faculty of Medicine Assaf Harofeh Medical Center, İsrail / Endoüroloji, Üroonkoloji Fellowship
- 1992–1997Marmara University Faculty of Medicine Department of Urology, Specialty Training
Memberships
Professional Memberships
- Endoüroloji Association
- Türk Androloji Association
- European Urology Association
- Turkish Urology Association
- Turkish Uro-Oncology Association
Selected publications
Selected Publications
- Lack of effect of intrarectal lidocaine for pain control during transrectal biopsy: A randomized prospective study. Eur Urol, 29:189-192, 2002 Çevik İ., Özveri H., Dillioğlugil Ö., Akdaş A.
- The role of bisphosphonates in the treatment of prostate cancer. Actual Medicine, 11: 4, 14-16, 2003 A. Akdaş, H. Özveri, İ. Çevik.
- Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study. Prostate Cancer and Prostatic Diseases, 6:311-314, 2003 Özveri H. , Çevik İ., Dillioğlugil Ö., Akdaş A.
- Lack of effect of intrarectal lidocaine for pain control during transrectal biopsy: A randomized prospective study. Eur Urol, 29:189-192, 2002 Çevik İ., Özveri H., Dillioğlugil Ö., Akdaş A.
- The place of neadjuvant chemotherapy in invasive bladder cancer. Int J. Urol. Nephrol, 33(1): 49-52. 2002 Çam K., Yıldırım A., Özveri H., Türkeri L., Akdaş A.
- The role of prostate specific antigen, Gleason score, digital rectal examination, and transrectal ultrasonography in the prediction of extracapsular prostate cancer. Ozveri H, Cam K, Turkeri L, Tarcan T, Akdas A. J of BUON, 6 (1):87-90 (2001)
- Early diagnosis of prostate cancer among 1181 patients attending an urology outpatient department. J of BUON, 5:389-392 (2000) Özveri H, Çam K, Tarcan T, Türkeri L, Akdaş A.
- Alteration of Epidermal Growth Factor Receptor Expression Following Ischaemia of Renal Tissue. Int. J. Urol and Nephrol 31 (5), pp 611-617, 1999 Ertugrul A., Türkeri L.N., Özyürek M., Özveri H., Akdaş A.
- The role of Hypoechoic lesion directed biopsies and free to total PSA ratio in diagnosis of prostate cancer patients with normal DRE and total PSA levels between 4-20 ng/ml. Proceedings of 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer. Tokyo, Japan. P:123-126, 1998 Özveri H , Çam K, Özveren B, Türkeri L, Akdaş A.
